Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Conte

Showing results (61-70 of 200) with videos related to

Pageof 20
Sort By:
La Radiologia Medica|May 1, 1990
[The role of radiotherapy in the multimodal treatment of locally advanced breast carcinoma]M Guenzi, D Scarpati, R Corvò, et al.
Tumori|June 30, 1984
Ineffectiveness of 5-fluorouracil and cis-platin as second-line chemotherapy in head and neck cancerM Merlano, P F Conte, R Tatarek, et al.
Tumori|August 31, 1993
A phase I-II study of oral doxifluridine plus radiotherapy in radiosensitive tumors of the pelvic regionS Spagnesi, F Ducci, M Laddaga, et al.
European Journal of Gynaecological Oncology|October 31, 2003
Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma?A Gadducci, S Cosio, A Fanucchi, et al.
Seminars in Oncology|March 4, 2000
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancerA Gennari, S Donati, R Danesi, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1994
In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinomaE Baldini, P G Giannessi, G Gardin, et al.
Cancer|January 15, 1995
Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II studyA Falcone, E Pfanner, C Cianci, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancerA Gadducci, I Brunetti, M P Muttini, et al.
Journal of Endocrinological Investigation|June 16, 2001
Increased prevalence of primary hyperparathyroidism in treated breast cancerP Fierabracci, A Pinchera, P Miccoli, et al.
Gynecologic Oncology|January 19, 2000
Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-OvestA Gadducci, F Carnino, S Chiara, et al.
Pageof 20

Showing results (61-70 of 200) with videos related to

Sort By:
Pageof 20
La Radiologia Medica|May 1, 1990
[The role of radiotherapy in the multimodal treatment of locally advanced breast carcinoma]M Guenzi, D Scarpati, R Corvò, et al.
Tumori|June 30, 1984
Ineffectiveness of 5-fluorouracil and cis-platin as second-line chemotherapy in head and neck cancerM Merlano, P F Conte, R Tatarek, et al.
Tumori|August 31, 1993
A phase I-II study of oral doxifluridine plus radiotherapy in radiosensitive tumors of the pelvic regionS Spagnesi, F Ducci, M Laddaga, et al.
European Journal of Gynaecological Oncology|October 31, 2003
Is pretreatment hemoglobin level a predictor of complete response to salvage chemotherapy for recurrent platinum-pretreated ovarian carcinoma?A Gadducci, S Cosio, A Fanucchi, et al.
Seminars in Oncology|March 4, 2000
The gemcitabine/epirubicin/paclitaxel combination in advanced breast cancerA Gennari, S Donati, R Danesi, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1994
In vivo cytokinetic effects of recombinant human growth hormone (rhGH) in patients with advanced breast carcinomaE Baldini, P G Giannessi, G Gardin, et al.
Cancer|January 15, 1995
Suramin in patients with metastatic colorectal cancer pretreated with fluoropyrimidine-based chemotherapy. A phase II studyA Falcone, E Pfanner, C Cianci, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancerA Gadducci, I Brunetti, M P Muttini, et al.
Journal of Endocrinological Investigation|June 16, 2001
Increased prevalence of primary hyperparathyroidism in treated breast cancerP Fierabracci, A Pinchera, P Miccoli, et al.
Gynecologic Oncology|January 19, 2000
Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-OvestA Gadducci, F Carnino, S Chiara, et al.
Pageof 20